Rockeby Biomed

Perth-based biotechnology company Rockeby biomed has withdrawn from acquisition talks with Chinese company Beijing AnHeal Laboratories Co.

Biotechnology company Rockeby Biomed Ltd has announced plans to raise $2 million through a share purchase plan to existing shareholders, to help fund the international expansion of the company's existing products and continue research and development acti

West Perth-based biotechnology company Rockeby Biomed Ltd has raised $1.5 million through a placement, with funds raised going towards covering working capital costs, future research and development of existing products.

Announced that it had signed a Memorandum of Understanding (MOU) with Pacific Biotech, whereby Pacific Biotech will assign the ownership of the avian and human influenza rapid diagnostic tests to Rock

West Perth-based biotechnology company Rockeby Biomed Ltd has signed a Memorandum of Understanding with Pacific Biotech, whereby Pacific will assign the ownership of the avian and human influenza rapid diagnostic tests to Rockeby .

West Perth-based biotechnology company Rockeby Biomed Ltd has announced that it has received and dispatched an order for 7,000 of its rapid diagnostic tests for Avian (or Bird) Flu to Romania.

Has secured the exclusive deal to supply its Avian Influenza Antigen Test to the Turkish Poultry Industry

West Perth-based biotechnology company Rockeby Biomed Ltd has completed further distribution deals in Europe for its Avian bird flu diagnostics as the strain of avian influenza A, H5N1, spreads from Asia to the European Union.

Perth-based biotechnology company Rockeby Biomed Ltd has completed further distribution deals for its Avian bird flu diagnostics in Europe, Asia and the Middle East.

8-Nov-05 Lim Chye Huat ceased to be a substantial shareholder.

Rockeby Biomed Ltd 05-Aug-05 Thorney Pty Ltd ceased to be a substantial shareholder.

1,600,000 ordinary shares will be released from escrow on August 28.

Lodged response to ASX query.

Rockeby Biomed Ltd General Meeting will be held on or about 12 July, 2004. Further details to be advised.